Mannose binding lectin and FcγRIIa (CD32) polymorphism in Spanish systemic lupus erythematosus patients

被引:52
作者
Villarreal, J
Crosdale, D
Ollier, W
Hajeer, A
Thomson, W
Ordi, J
Balada, E
Villardell, M
Teh, LS
Poulton, K
机构
[1] Hosp Gen Valle Hebron, Barcelona, Spain
[2] Univ Manchester, Sch Med, Sch Epidemiol & Hlth Sci, Arthrit & Rheumatism Campaign Epidemiol Unit, Manchester M13 9PT, Lancs, England
[3] Blackburn Royal Infirm, Dept Rheumatol, Blackburn BB2 3LR, Lancs, England
[4] Manchester Royal Infirm, Manchester Inst Nephrol & Transplantat, Manchester M13 9WL, Lancs, England
关键词
MBL; Fc gamma RIIa; polymorphism; SLE;
D O I
10.1093/rheumatology/40.9.1009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. Mannose binding lectin (MBL) and Fc gamma RII (CD32) polymorphisms have both been implicated as candidate susceptibility genes in systemic lupus erythematosus (SLE). The aim of this study was to evaluate the relationship of these polymorphisms with SLE. Methods. We studied a cohort of 125 SLE patients from Barcelona, Spain and 138 geographically matched controls. Sequence-specific primer-polymerase chain reaction (SSP-PCR) amplification was used to determine CD32 and MBL structural polymorphisms. MBL haplotypes were established using sequence-specific oligonucleotide probing techniques. Results. Patients carried the MBL codon 54 mutant allele more frequently than controls [odds ratio (OR) 2.2; 95% confidence interval (CI) 1.2-4.0; P=0.007] and the haplotype HY W52 W54 W57 was found to be significantly lower in cases compared with controls (OR 0.6; 95% CI 0.4-0.9; P=0.016). Conclusion. The MBL gene codon 54 mutant allele appears to be a risk factor for SLE, whilst haplotypes encoding for high levels of MBL are protective against the disease. Differences between controls and patients were not significant when considering the Fc gamma RIIa polymorphisms; similar results were observed for renal affectation.
引用
收藏
页码:1009 / 1012
页数:4
相关论文
共 26 条
  • [1] Fc gamma RIIa polymorphism in systemic lupus erythematosus (SLE): No association with disease
    Bottto, M
    Theodoridis, E
    Thompson, EM
    Beynon, HLC
    Briggs, D
    Isenberg, DA
    Walport, MJ
    Davies, KA
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1996, 104 (02) : 264 - 268
  • [2] Mannose binding lectin (MBL) genotype distributions with relation to serum levels in UK Caucasoids
    Crosdale, DJ
    Ollier, WER
    Thomson, W
    Dyer, PA
    Jensenious, J
    Johnson, RWG
    Poulton, KV
    [J]. EUROPEAN JOURNAL OF IMMUNOGENETICS, 2000, 27 (03): : 111 - 117
  • [3] MANNOSE-BINDING PROTEIN GENE POLYMORPHISM IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    DAVIES, EJ
    SNOWDEN, N
    HILLARBY, MC
    CARTHY, D
    GRENNAN, DM
    THOMSON, W
    OLLIER, WER
    [J]. ARTHRITIS AND RHEUMATISM, 1995, 38 (01): : 110 - 114
  • [4] Davies EJ, 1997, J RHEUMATOL, V24, P485
  • [5] DEAPEN D, 1992, ARTHRITIS RHEUM, V35, P311
  • [6] DUITS AJ, 1995, ARTHRITIS RHEUM, V39, P1832
  • [7] A HUMAN MANNOSE-BINDING PROTEIN IS AN ACUTE-PHASE REACTANT THAT SHARES SEQUENCE HOMOLOGY WITH OTHER VERTEBRATE LECTINS
    EZEKOWITZ, RAB
    DAY, LE
    HERMAN, GA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 167 (03) : 1034 - 1046
  • [8] LACHMANN PJ, 1991, PROGR IMMUNE DEFICIE, V3
  • [9] Mannose-binding protein in Chinese patients with systemic lupus erythematosus
    Lau, YL
    Lau, CS
    Chan, SY
    Karlberg, J
    Turner, MW
    [J]. ARTHRITIS AND RHEUMATISM, 1996, 39 (04): : 706 - 708
  • [10] Lipscombe R. J., 1992, Human Molecular Genetics, V1, P709, DOI 10.1093/hmg/1.9.709